Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Feb 27, 2014, after the close
10-K filed Feb 27, 2014, 58 days after period end · 0001193125-14-073040
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $37.00K | $380.00K | $588.00K | — |
| Net Income | -$12.05M | -$6.81M | -$5.30M | — |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.13 |
| -$0.11 |
| -$0.10 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
